Skip to main content
. 2022 Aug;33(8):1459–1470. doi: 10.1681/ASN.2021121605

Figure 1.

Figure 1.

Graphical representation of the continuum between explanatory and pragmatic trials. Less control in pragmatic trials often comes with a broader population enrolled and more generalizability of the results. The downside is more heterogeneity in response to therapies in the enrolled population.